Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Research|April 15, 2010
Oncogenic role of miR-483-3p at the IGF2/483 locusAngelo Veronese, Laura Lupini, Jessica Consiglio, et al.
The Journal of Pathology|June 2, 2011
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-originManuela Ferracin, Massimo Pedriali, Angelo Veronese, et al.
Japanese Journal of Clinical Oncology|January 5, 2011
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological featuresElia Biganzoli, Danila Coradini, Federico Ambrogi, et al.
Biomarker Research|June 30, 2015
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCRAlessandra Mangolini, Manuela Ferracin, Maria Vittoria Zanzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patientsPatrizia Querzoli, Massimo Pedriali, Rosa Rinaldi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 15, 2019
Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literatureMaria P Foschini, Rossella Miglio, Roberta Fiore, et al.
Molecular Cancer Therapeutics|March 15, 2023
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer VulnerabilityEmanuela Guerra, Marco Trerotola, Valeria Relli, et al.
Virchows Archiv : an International Journal of Pathology|July 6, 2016
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancerJelle Wesseling, Corrado Tinterri, Anna Sapino, et al.
Cancer Research|August 17, 2005
MicroRNA gene expression deregulation in human breast cancerMarilena V Iorio, Manuela Ferracin, Chang-Gong Liu, et al.
Breast Cancer Research and Treatment|April 12, 2011
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective studyManuela Campiglio, Rosaria Bufalino, Marco Sandri, et al.
Pageof 4